HK1208223A1 - 1,2,4-triazine derivatives for the treatment of viral infections 124- - Google Patents

1,2,4-triazine derivatives for the treatment of viral infections 124-

Info

Publication number
HK1208223A1
HK1208223A1 HK15108914.9A HK15108914A HK1208223A1 HK 1208223 A1 HK1208223 A1 HK 1208223A1 HK 15108914 A HK15108914 A HK 15108914A HK 1208223 A1 HK1208223 A1 HK 1208223A1
Authority
HK
Hong Kong
Prior art keywords
treatment
viral infections
triazine derivatives
triazine
derivatives
Prior art date
Application number
HK15108914.9A
Other languages
English (en)
Chinese (zh)
Inventor
‧跟巴斯
‧朱博
‧瓦羅
‧勒瓦謝
‧邦凡蒂
‧麥克格文
‧吉耶蒙
Original Assignee
Centre Nat Rech Scient
Univ Rouen
Inst Nat Sciences Appliq
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Rouen, Inst Nat Sciences Appliq filed Critical Centre Nat Rech Scient
Publication of HK1208223A1 publication Critical patent/HK1208223A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epidemiology (AREA)
HK15108914.9A 2012-10-01 2015-09-11 1,2,4-triazine derivatives for the treatment of viral infections 124- HK1208223A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12306196.2A EP2712866A1 (en) 2012-10-01 2012-10-01 1,2,4-triazine derivatives for the treatment of viral infections
PCT/EP2013/070488 WO2014053516A1 (en) 2012-10-01 2013-10-01 1,2,4-triazine derivatives for the treatment of viral infections.

Publications (1)

Publication Number Publication Date
HK1208223A1 true HK1208223A1 (en) 2016-02-26

Family

ID=46982496

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15108914.9A HK1208223A1 (en) 2012-10-01 2015-09-11 1,2,4-triazine derivatives for the treatment of viral infections 124-

Country Status (22)

Country Link
US (1) US9416114B2 (hu)
EP (2) EP2712866A1 (hu)
JP (1) JP6298998B2 (hu)
KR (1) KR102138393B1 (hu)
CN (1) CN104812747B (hu)
AU (1) AU2013326579B2 (hu)
BR (1) BR112015007310B1 (hu)
CA (1) CA2886630C (hu)
CL (1) CL2015000787A1 (hu)
EA (1) EA026236B1 (hu)
ES (1) ES2616496T3 (hu)
HK (1) HK1208223A1 (hu)
IL (1) IL237871A (hu)
IN (1) IN2015DN03327A (hu)
MX (1) MX348229B (hu)
MY (1) MY182558A (hu)
NZ (1) NZ706354A (hu)
PH (1) PH12015500724A1 (hu)
SG (1) SG11201502522WA (hu)
UA (1) UA114644C2 (hu)
WO (1) WO2014053516A1 (hu)
ZA (1) ZA201502240B (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS57758B1 (sr) 2011-04-08 2018-12-31 Janssen Sciences Ireland Uc Pirimidinski derivati za tretman viralnih infekcija
IN2014MN00862A (hu) 2011-11-09 2015-04-17 Janssen R & D Ireland
LT2872515T (lt) 2012-07-13 2016-10-10 Janssen Sciences Ireland Uc Makrocikliniai purinai, skirti virusinių infekcijų gydymui
NZ705589A (en) 2012-10-10 2019-05-31 Janssen Sciences Ireland Uc Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
US9663474B2 (en) 2012-11-16 2017-05-30 Janssen Sciences Ireland Uc Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections
US9598378B2 (en) 2013-02-21 2017-03-21 Janssen Sciences Ireland Uc 2-aminopyrimidine derivatives for the treatment of viral infections
AU2014242954B2 (en) 2013-03-29 2018-03-15 Janssen Sciences Ireland Uc Macrocyclic deaza-purinones for the treatment of viral infections
CN105377833B (zh) 2013-05-24 2018-11-06 爱尔兰詹森科学公司 用于治疗病毒感染和另外的疾病的吡啶酮衍生物
MX361527B (es) 2013-06-27 2018-12-07 Janssen Sciences Ireland Uc Derivados de pirrolo[3,2-d]pirimidina para el tratamiento de infecciones víricas y otras enfermedades.
JP6401788B2 (ja) 2013-07-30 2018-10-10 ヤンセン・サイエンシズ・アイルランド・ユーシー ウイルス感染治療用チエノ[3,2−d]ピリミジン誘導体
CA3027471A1 (en) 2016-07-01 2018-01-04 Janssen Sciences Ireland Unlimited Company Dihydropyranopyrimidines for the treatment of viral infections
EA038646B1 (ru) * 2016-09-29 2021-09-28 Янссен Сайенсиз Айрлэнд Анлимитед Компани Пиримидиновые пролекарства для лечения вирусных инфекций и других заболеваний
TW201945003A (zh) 2018-03-01 2019-12-01 愛爾蘭商健生科學愛爾蘭無限公司 2,4-二胺基喹唑啉衍生物及其醫學用途
WO2020162705A1 (ko) 2019-02-08 2020-08-13 성균관대학교산학협력단 톨-유사 수용체 7 또는 8 작용자와 콜레스테롤의 결합체 및 그 용도
US20230100429A1 (en) 2020-03-02 2023-03-30 Progeneer Inc. Live-pathogen-mimetic nanoparticles based on pathogen cell wall skeleton, and production method thereof
CN116056725A (zh) 2020-08-04 2023-05-02 蛋白科技先鋒 活性位点暂时灭活的功能性药物与Toll样受体7或8激动剂的缀合物及其用途
JP2023536945A (ja) 2020-08-04 2023-08-30 プロジェニア インコーポレイテッド 動力学的に作用するアジュバントアンサンブル
WO2022031021A1 (ko) 2020-08-04 2022-02-10 성균관대학교산학협력단 동력학적 제어가 가능한 아주번트를 포함하는 mrna 백신
WO2024151953A1 (en) * 2023-01-15 2024-07-18 Viradem Inc. Compounds and methods for treating diseases caused by sars-cov-2 and other coronaviruses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485531A1 (fr) * 1980-06-25 1981-12-31 Fabre Sa Pierre Nouveaux n-oxydes de diaryl-5,6 as triazines 1-2-4, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
WO1998001448A1 (fr) 1996-07-03 1998-01-15 Japan Energy Corporation Nouveaux derives de purine
NZ504800A (en) 1997-11-28 2001-10-26 Sumitomo Pharma 6-Amino-9-benzyl-8-hydroxy-purine derivatives and interferon inducers, antiviral agents, anticancer agents and therapeutic agents for immunologic diseases thereof
CN101035773B (zh) * 2004-08-10 2012-06-06 詹森药业有限公司 抑制hiv的1,2,4-三嗪-6-酮衍生物
AU2006242920A1 (en) 2005-05-04 2006-11-09 Pfizer Limited 2-amido-6-amino-8-oxopurine derivatives as Toll-Like receptor modulators for the treatment of cancer and viral infections, such as hepatitis C
EP1924564B1 (en) * 2005-09-01 2016-11-09 F.Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p2x2/3 modulators
RU2352565C1 (ru) * 2007-10-08 2009-04-20 Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" 3-амино-6-ароилметил-5-гидрокси-1,2,4-триазины и способ их получения
PE20091236A1 (es) * 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
WO2012067269A1 (en) * 2010-11-19 2012-05-24 Dainippon Sumitomo Pharma Co., Ltd. Aminoalkoxyphenyl compounds and their use in the treatment of disease

Also Published As

Publication number Publication date
EP2712866A1 (en) 2014-04-02
EP2903976B1 (en) 2016-12-07
IL237871A (en) 2017-04-30
ZA201502240B (en) 2016-05-25
SG11201502522WA (en) 2015-05-28
KR102138393B1 (ko) 2020-08-14
IN2015DN03327A (hu) 2015-10-09
PH12015500724B1 (en) 2015-06-01
ES2616496T3 (es) 2017-06-13
CN104812747A (zh) 2015-07-29
MX348229B (es) 2017-05-31
KR20150084791A (ko) 2015-07-22
CA2886630A1 (en) 2014-04-10
NZ706354A (en) 2018-08-31
WO2014053516A1 (en) 2014-04-10
EP2903976A1 (en) 2015-08-12
CA2886630C (en) 2021-01-26
US20150336907A1 (en) 2015-11-26
UA114644C2 (uk) 2017-07-10
US9416114B2 (en) 2016-08-16
JP6298998B2 (ja) 2018-03-28
CL2015000787A1 (es) 2015-10-02
BR112015007310A2 (pt) 2017-08-08
EA026236B1 (ru) 2017-03-31
AU2013326579B2 (en) 2017-04-27
MX2015004160A (es) 2016-02-05
BR112015007310B1 (pt) 2022-07-19
PH12015500724A1 (en) 2015-06-01
AU2013326579A1 (en) 2015-04-09
MY182558A (en) 2021-01-25
CN104812747B (zh) 2017-03-08
EA201500383A1 (ru) 2015-07-30
JP2015535839A (ja) 2015-12-17

Similar Documents

Publication Publication Date Title
HK1208223A1 (en) 1,2,4-triazine derivatives for the treatment of viral infections 124-
HK1256490A1 (zh) 用於治療病毒感染的嘧啶衍生物
ZA201405820B (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
HK1211589A1 (en) Compounds for the treatment of paramoxyvirus viral infections
ZA201603123B (en) Pyrrolo [1,2,f] [1,2,4] triazines useful for treating respiratory syncitial virus infections
HK1213569A1 (zh) 用於治療病毒性感染的 -氨基嘧啶衍生物
ZA201500921B (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diaseases
SG11201503042QA (en) Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
IL240765A0 (en) Macrocyclic daza-furanones for the treatment of viral infections
ZA201306342B (en) The treatment of viral infections
TH1501001789A (th) อนุพันธ์ของ 1,2,4-ไตรอะซีน สำหรับการบำบัดของโรคติดเชื้อไวรัส

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20231001